Vor Biopharma Inc.
VOR
$2.17
-$0.03-1.36%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 234.08% | -34.69% | 46.36% | -26.91% | -20.04% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -66.78% | 7.47% | -0.02% | 3.86% | 5.61% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 863.64% | -21.84% | 33.33% | 4.78% | -46.35% |
| Total Current Assets | 216.02% | -32.81% | 43.41% | -25.44% | -19.28% |
|
|
|||||
| Total Current Assets | 216.02% | -32.81% | 43.41% | -25.44% | -19.28% |
| Net Property, Plant & Equipment | -99.94% | -4.58% | -4.99% | -4.55% | -4.43% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -91.22% | -0.29% | -2.62% | -10.06% | -24.28% |
| Total Assets | 87.88% | -23.50% | 23.19% | -18.08% | -15.23% |
|
|
|||||
| Total Accounts Payable | -82.07% | 147.97% | 14.36% | -34.43% | -13.68% |
| Total Accrued Expenses | 569.02% | -32.63% | 45.41% | 15.43% | 10.82% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 1.21% | 1.25% | 1.22% | 3.94% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 251.37% | -10.13% | 29.75% | 3.94% | 4.45% |
|
|
|||||
| Total Current Liabilities | 251.37% | -10.13% | 29.75% | 3.94% | 4.45% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -3.98% | -3.75% | -3.42% | -3.49% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3,856.87% | -6.46% | 7.41% | -1.08% | -1.11% |
|
|
|||||
| Common Stock & APIC | 0.34% | 0.34% | 10.91% | 0.46% | 0.58% |
| Retained Earnings | -321.50% | -7.11% | -7.20% | -6.91% | -7.51% |
| Treasury Stock & Other | -39.13% | 4.55% | -67.65% | 197.14% | 19.54% |
| Total Common Equity | -2,378.98% | -31.65% | 32.50% | -25.62% | -20.28% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2,378.98% | -31.65% | 32.50% | -25.62% | -20.28% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2,378.98% | -31.65% | 32.50% | -25.62% | -20.28% |
|
|
|||||